These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1414152)

  • 21. Naloxone attenuates development of hypertension in DOCA-salt hypertensive rats.
    Zhai SD; Malvin RL
    Clin Exp Hypertens A; 1991; 13(1):133-42. PubMed ID: 2022070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.
    Ito H; Majima M; Nakajima S; Hayashi I; Katori M; Izumi T
    Br J Pharmacol; 1999 Feb; 126(3):613-20. PubMed ID: 10188971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
    Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic treatment with anti-endothelin antibodies fails to modify the development of hypertension in stroke-prone spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Yasujima M; Kanazawa M; Yoshida K; Kohzuki M; Watanabe H; Hiwatari M; Sato T; Abe K; Hirata Y; Yoshinaga K
    Tohoku J Exp Med; 1993 Jan; 169(1):43-50. PubMed ID: 8211968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O
    Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 1998 Jan; 31(1 Pt 2):403-8. PubMed ID: 9453336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats.
    Kh R; Khullar M; Kashyap M; Pandhi P; Uppal R
    J Hypertens; 2000 Jul; 18(7):919-26. PubMed ID: 10930190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
    Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
    Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.
    Boesen EI; Williams DL; Pollock JS; Pollock DM
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1016-22. PubMed ID: 20626757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y; Kita S; Morimoto S; Akimoto K; Furuya M; Oka N; Tanaka T
    Biol Pharm Bull; 1995 Jul; 18(7):1016-9. PubMed ID: 7581242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.